Log in  First Connection?

VaccinesArchives

Vaccine adjuvants as stand-alone immunoprophylaxis in strategies for 100-day rapid responses to future pandemics
Vaccines
 1 min.

 Published on 02/04/2026 |  Original article (Full-text)  | Niloufar Kavian et al. | International Immunology. Volume 38(2).

The COVID-19 pandemic accelerated vaccinology progress, driving rapid vaccine development for infectious and non-infectious diseases. However, challenges persist: malaria, HIV, and dengue lack fully effective vaccines, whereas influenza and tuberculosis face waning efficacy. Emerging pathogens and drug-resistant...

Imprecision in tuberculosis infection outcomes: implications for non-inferiority vaccine trials
Vaccines
 1 min.

 Published on 26/03/2026 |  Original article (Full-text)  | Daniel J Grint et al. | International journal of epidemiology. Volume 55(2).

Randomized trials comparing new vaccines against tuberculosis for use in neonates and infants, for whom Bacille Calmette-Guérin vaccination is established practice, are using tuberculosis infection as the primary endpoint in a non-inferiority design. Markers of tuberculosis infection have imperfect...

Comparing standard versus intensified pneumococcal vaccination regimens in patients with inflammatory bowel disease on biologics: a prospective, multicenter, randomized, open-label study
Vaccines
 1 min.

 Published on 19/03/2026 |  Original article (Full-text)  | Xavier Roblin et al. | Journal of Crohn's and Colitis. Volume 19(7).

Pneumococcal vaccination is essential for patients with inflammatory bowel diseases (IBD), but its efficacy is reduced in those on antitumor necrosis factor (TNF) or immunosuppressive therapy. This study compared immune responses to standard versus intensified pneumococcal vaccination strategies in IBD...

Knowledge on modes of hepatitis B transmission and the practice of family screening and vaccination among patients with chronic hepatitis B infection at a tertiary center in Ethiopia
Vaccines
 5 min.

 Published on 12/03/2026 |  Original article (Full-text)  | Anagaw Sewale et al. | BMC Gastroenterology 2026; 26(1): 154

Hepatitis B infection remains an important global public health problem with significant morbidity and mortality. It is estimated that 2 billion people have evidence of past or present infection with hepatitis B virus (HBV) worldwide [1, 2]. The World Health Organization (WHO) estimated that 296 million...

COVID-19 vaccine confidence among parents of racially diverse children aged 0–12 years old in Canada: The role of major experience of racial discrimination, health literacy, and conspiracy beliefs
Vaccines
 1 min.

 Published on 05/03/2026 |  Original article (Full-text)  | Seyed Mohammad Mahdi Moshirian Farahi et al. | Human vaccines & immunotherapeutics 2025; 21(1):

The success of COVID-19 vaccination is linked to trust, hesitancy, and confidence. Racial discrimination impacts vaccine hesitancy and trust, particularly in racialized groups. This study investigates factors influencing COVID-19 vaccine confidence among Canadian parents from different racial groups,...